Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model

Drug Delivery and Translational Research(2024)10.1007/s13346-024-01562-5Source: DataRank Database

Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model is a research paper published in Drug Delivery and Translational Research (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.96)OA: hybridTopics (82)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Nina Filipczak ORCID,Tanvi Vinod Pathrikar ORCID,Colin Cotter,Janaína Artem Ataide ORCID,Ed Luther ORCID

Live enrichment

PubMed:38507033 PMC:PMC11208241 OpenAlex:https://openalex.org/W4392985645

Foundation for the National Institutes of Health

Grant: 1R01CA200844

NCI NIH HHS

Grant: R01 CA200844

National Institutes of Health

Grant: 5R01CA200844-02

Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer

Northeastern University USA

FWCI

0.96

Citation Percentile

0.7%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s13346-024-01562-5.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s13346-024-01562-5.pdf

publisherhttps://link.springer.com/article/10.1007/s13346-024-01562-5/fulltext.html

journalhttps://doi.org/10.1007/s13346-024-01562-5

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38507033

Fields of Study

RNA Interference and Gene DeliveryDendrimers and Hyperbranched PolymersDrug Transport and Resistance Mechanisms0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsDendrimersDoxorubicinRNA, Small InterferingFemaleMicellesHumansCell Line, TumorMaleXenograft Model Antitumor AssaysMiceMice, NudeAntibodies, MonoclonalAntibiotics, AntineoplasticCell MovementTriple Negative Breast Neoplasms

MeSH Terms

AnimalsAntibiotics, AntineoplasticAntibodies, MonoclonalCell MovementDoxorubicinFemaleHumansMaleMice, NudeMicellesXenograft Model Antitumor AssaysRNA, Small InterferingCell Line, TumorDendrimersMiceTriple Negative Breast Neoplasms

Keywords

DoxorubicinChemistryMultiple drug resistanceMicellePharmacologyDrug resistanceCancer researchDrugMetastasisMonoclonal antibodyCancerAntibodyChemotherapyMedicineImmunologyBiologyBiochemistryInternal medicineAntibioticsMicrobiologyBreast cancerIn vivoNanoparticlesSiRNADendrimerPreclinical ModelCo-deliveryMaleDendrimersAntibiotics, AntineoplasticMice, NudeAntibodies, MonoclonalTriple Negative Breast NeoplasmsXenograft Model Antitumor AssaysArticleMiceCell MovementCell Line, TumorAnimalsHumansOriginal ArticleFemaleRNA, Small InterferingMicelles

Sustainable Development Goals

SDG 0: Good health and well-being